What is the active ingredient in Zetia (ezetimibe)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Active Ingredient in Zetia

The active ingredient in Zetia is ezetimibe, a selective cholesterol absorption inhibitor that works by blocking the Niemann-Pick C1-Like 1 (NPC1L1) protein in the small intestine. 1

Chemical Composition and Formulation

  • The chemical name of ezetimibe is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, with an empirical formula of C24H21F2NO3 and molecular weight of 409.4 1

  • Each Zetia tablet contains 10 mg of ezetimibe as the sole active pharmaceutical ingredient 1

  • The inactive ingredients include lactose monohydrate, croscarmellose sodium, hypromellose, sodium lauryl sulfate, crospovidone, microcrystalline cellulose, and magnesium stearate 1

Mechanism of Action

  • Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine through blocking the sterol transporter NPC1L1, which is involved in the intestinal uptake of cholesterol and phytosterols 1, 2

  • The drug localizes at the brush border of the small intestine and inhibits cholesterol absorption, leading to decreased delivery of intestinal cholesterol to the liver 1

  • This mechanism causes a reduction of hepatic cholesterol stores and an increase in LDL receptors, resulting in enhanced clearance of cholesterol from the blood 1

  • Ezetimibe's mechanism is distinct from statins (which inhibit cholesterol synthesis) and bile acid sequestrants (which bind bile acids) 3

Clinical Efficacy

  • As monotherapy, ezetimibe reduces LDL-C by approximately 18% 2, 4

  • When combined with statin therapy, ezetimibe provides an additional 25% incremental reduction in LDL-C beyond statin therapy alone 2, 4

  • In clinical trials, ezetimibe inhibited intestinal cholesterol absorption by 54% compared with placebo 1

References

Guideline

Ezetimibe Dosage and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mechanism and Clinical Applications of Ezetimibe

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.